abstract |
The present invention relates to pyrazolyl compounds of Formulas Ia and Ib that are useful for inhibiting Raf kinase and for treating disorders mediated by it. Methods for using pyrazolyl compounds for the diagnosis, prevention or treatment in vitro, in situ and in vivo of these disorders in mammalian cells or associated pathological conditions are described. |